Find a Doctor or Practice Location

Are you a referring physician?
I am searching for a
Reset Form
Priti Lal, MD

Priti Lal, MD Physician

Associate Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania

Dr. Lal is employed by Penn Medicine.

No Patient Satisfaction Reviews
Why not?

There is no publicly available rating for this medical professional for one of the following reasons:

  1. He or she is not employed by Penn Medicine.
  2. He or she does not see patients.
  3. He or she sees patients but has not yet received the minimum 30 patient satisfaction reviews in the past 12 months, ensuring that the rating is statistically reliable and a true reflection of patient satisfaction.

Clinical Specialties


  • Pathology and Laboratory Medicine

Programs & Centers:

Board Certification:

  • Pathology - Anatomic Pathology, 2010

Description of Clinical Expertise

GU Pathology. Cardiovascular and renal transplantation pathology.

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Maulana Azad Medical College University of Delhi
Fellowship: National Institutes of Health
Residency: University of Medicine and Dentistry of New Jersey
Fellowship: Armed Forces Institute
Fellowship: Memorial Sloan-Kettering Cancer Center


AACR, National ASCO, International College of American Pathologists, National ISUP, International Pennsylvania Association of Pathologists, Local

Hospital Affiliation

Dr. Lal is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.


Description of Research Expertise:

Application of high through-put technology to gain insights into the biology of human cancers, with special interest in GU cancers.

Selected Publications:

Priti Lal, Kosj Yamoah, Amy Ziober, Amy Walker, Wenting Zhou, Elaine Spangler, Charnita Zeigler-Johnson, Michael Feldman, Timothy R. Rebbeck.: Racial Differences in the Distribution of Prostate Tumor Biomarkers and Treatment Failure: The SCORE Study Clinical Cancer Research : 2015.

Kosj Yamoah, Michael Hiroshi Johnson, Voleak Choeurng, Kasra Yousefi, Zaid Haddad, Robert Benjamin Den, Priti Lal, Michael D Feldman, Adam Dicker, Eric A. Klein, Elai Davicioni, Timothy R. Rebbeck, Edward M. Schaeffer: A novel biomarker signature which may predict aggressive disease in African-American men with prostate cancer. Journal of Clinical oncology : 2015.

Kosj Yamoah, M.D., Ph.D.; Amy Walker, M.S.; Elaine Spangler, M.S.; Charnita M Zeigler-Johnson, M.D., Ph.D.; Bruce Malkowicz, M.D.; David I Lee, M.D.; Adam P Dicker, M.D., Ph.D.; Priti Lal, M.D.: African-American race is a predictor of seminal vesicle invasion following radical prostatectomy. Clinical Genitorurinary Cancer : 2014.

Priti Lal, MD: Chapter 39: Prostate. Diagnostic molecular pathology. Diagnostic Molecular pathology, 2nd edition : 2015.

David J. Vaughn, MD, Wei-Ting Hwang, PhD, Priti Lal, MD, Mark Rosen, MD Maryann Gallagher, Peter J. O’Dwyer, MD: Phase II Trial of the CDK 4/6 Inhibitor Palbociclib in Patients with Retinoblastoma Protein Expressing Germ Cell Tumors Cancer : 2014.

Stephen Michael Keefe, Daniel Heitjan, Meliessa Hennessey, Janelle Robinson, Kristine Mykulowicz, Amy Marshall, Orvar Gunnarsson, Ronac Mamtani, David J. Vaughn, Jean H. Hoffman-Censits, Katherine L. Nathanson, Priti Lal, Daniel A. Pryma, Scott Eliasof, Edward Graeme Garmey, Roger B. Cohen, Naomi B. Haas;: Interim results of a phase 1b/2a study evaluating the nano pharmaceutical CRLX101 with bevacizumab (bev) in the treatment of patients (pts) with refractory metastatic renal cell carcinoma (mRCC). ASCO : 2014.

Mathew LK, Lee SS, Skuli N, Rao S, Keith B, Nathanson KL, Lal P, Simon MC: Restricted Expression of miR-30c-2-3p and miR-30a-3p in Clear Cell Renal Cell Carcinomas Enhances HIF2α Activity. Cancer Discov 4 (1): 53-60,2014.

Priti Lal, MD: Applications of OCT 4 in Diagnostic immunohistochemistry Leong's Manual of Diagnostic Antibodies for Immunohistology 3rd edition : 2014.

Priti Lal, MD: Application of GATA 3 in diagnostic immunohistochemistry Leong's Manual of Diagnostic Antibodies for Immunohistology 3rd edition : 2014.

Priti Lal, MD: Application of SALL4 in diagnostic immunohistochemistry Leong's Manual of Diagnostic Antibodies for Immunohistology 3rd edition : 2014.

Academic Contact Info

Department of Pathology and Laboratory Medicine
Hospital of the University of Pennsylvania
6 Founders Pavilion
3400 Spruce Street

Philadelphia, PA 19104-4283
Phone: (215) 662-6505
Patient appointments: 800-789-7366 (PENN)

Related Links